Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections

Table 1

Baseline characteristics of newly diagnosed and long-standing T2DM patients.

	CSII group	MDI3 group	MDI4 group
N	n = 39	n = 38	n = 39
L	n = 43	n = 41	n = 43
Age (years)
N	55.10 ± 10.02	52.95 ± 9.63	52.56 ± 9.97
L	59.68 ± 8.22	57.67 ± 10.82	58.89 ± 11.85
Men
N	19 (49%)	18 (47%)	19 (49%)
L	25 (58%)	21 (51%)	23 (53%)
Duration of diabetes (years)
N	No	No	No
L	12.34 ± 2.07	11.33 ± 1.14	13.28 ± 2.54
Body mass index (kg/m^2)
N	24.55 ± 2.90	25.72 ± 3.62	25.03 ± 2.84
L	24.73 ± 3.43	25.17 ± 3.29	24.66 ± 2.84
HbA1c (%)
N	9.65 ± 1.81	9.99 ± 1.75	10.13 ± 1.93
L	8.38 ± 1.68	8.18 ± 1.58	8.66 ± 1.73
Systolic blood pressure (mm Hg)
N	126.77 ± 12.55	127.05 ± 16.44	131.03 ± 15.56
L	129.12 ± 12.76	127.41 ± 15.28	132.33 ± 11.17
Diastolic blood pressure (mm Hg)
N	81.10 ± 9.84	81.64 ± 10.15	81.25 ± 6.78
L	82.72 ± 10.46	83.67 ± 11.41	83.06 ± 11.10
Fasting plasma glucose (mmol/L)
N	10.47 ± 2.62	11.07 ± 3.01	11.24 ± 2.94
L	9.32 ± 2.22	8.66 ± 2.75	9.56 ± 2.35
Fasting plasma insulin (mU/L)
N	5.58 ± 2.95	7.40 ± 8.84	6.79 ± 2.91
L	5.97 ± 2.86	6.01 ± 4.19	6.11 ± 3.15
Fasting plasma C-peptide (pmol/L)
N	2.23 ± 0.77	1.98 ± 1.07	2.36 ± 1.12
L	1.94 ± 0.60	2.41 ± 1.11	2.02 ± 0.62

Data are mean (SD) or (%). N: newly diagnosed T2DM patients group; L: long-standing T2DM patients group.